Hydrokortison Evolan

Hydrokortison Evolan is a topical dermatological preparation that contains the corticosteroid hydrocortisone as its active ingredient; the product’s strength is not specified in the available data. It is marketed within the European Union and is intended for external application to the skin. The formulation is designed to deliver anti‑inflammatory and immunosuppressive effects directly to affected areas, supporting the management of various inflammatory skin disorders in patients.

Hydrokortison Evolan is commonly used for the topical treatment of several inflammatory and pruritic skin conditions.

- Eczema, including atopic dermatitis - Contact dermatitis - Psoriasis - Seborrheic dermatitis - Other inflammatory skin disorders such as lichen planus

Topical hydrocortisone may cause local and, rarely, systemic adverse reactions.

Common: - Mild burning or stinging at the site of application - Transient itching or dryness - Local skin thinning (atrophy) with prolonged use

Serious: - Allergic contact dermatitis or severe skin irritation - Secondary bacterial, fungal or viral infection of the treated area - Systemic cortisol suppression when large areas are used extensively

Before using Hydrokortison Evolan, certain precautions should be considered to minimize risks and ensure appropriate therapy.

- Avoid application to broken, infected, or ulcerated skin unless directed by a clinician - Do not use on the face, groin, or axillae for prolonged periods unless advised - Limit duration of treatment, typically not exceeding two weeks without medical review - Keep out of eyes, mouth, and mucous membranes; wash hands after application - Use the smallest effective amount and avoid occlusive dressings unless prescribed - Pregnant or breastfeeding individuals should consult a healthcare professional before use

Topical hydrocortisone can interact with other medications or substances applied to the skin.

Avoid: - Concurrent use of other potent topical corticosteroids on the same area - Application of topical antibiotics or antifungals that may be inactivated by corticosteroid‑induced immunosuppression

Use with caution: - Systemic corticosteroids, which may increase risk of systemic effects - Photosensitizing agents, as skin may become more susceptible to UV damage - Herbal or over‑the‑counter skin products that could alter absorption